Neil Bodick - Chief Scientific Officer, Flexion Therapeutics Inc

As of January 7, 2020


Neil Bodick Net Worth

  • Net worth is estimated to be at least $2.39M
  • Owns at least 488,836 units of Flexion Therapeutics Inc stock
  • Sold an estimated value of $2.48M in the last 6 years at Flexion Therapeutics Inc

Neil Bodick Trading

  • Largest purchase of shares was 2,700 units , worth over $66.11K on November 22, 2017
  • Largest sale of shares was 50,000 units , worth over $1.25M on July 3, 2018
  • In total has made about 29 transactions over 6 years
  • Usually trades in March and May, with the busiest year in 2016 and 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Neil Bodick Mailing Address

  • Mailing address is C/o Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 MA

Flexion Therapeutics Inc Insider Trading

  • The most recent transaction was 3,945 units sold on July 20, 2021 by Christina Willwerth worth over $25.45K
  • In the last 7 years, insiders at Flexion Therapeutics Inc sold an estimated value of $36.93M and bought an estimated value of $69.1M
  • The most active traders are Michael Clayman, President and CEO,  Neil Bodick, Chief Scientific Officer,  and Samuel Colella, Director
  • Insider trading is most common in June, with the busiest year in 2021

Flexion Therapeutics Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1